Trial Profile
Schizophrenia sensory gating deficit with quetiapine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Oct 2009
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Biomarker; Therapeutic Use
- 11 Oct 2007 New trial record.